Clinical Trial

Caesar Foot Take-Home Validation Testing

Recruiting
View on ClinicalTrials.gov →
Summary
The rationale for this study is to conduct a take-home clinical trial to evaluate the impact of the bimodal Caesar foot in a real-world environment. Participants will take the device home and use it throughout their daily life for two months. A one-month baseline period, using their usual foot, will be completed both before and after the two-month period with the Caesar foot condition. Self-report surveys and performance-based measures will be collected in the clinic at the end of each condition. The intent of this study is to determine the Caesar foot's feasibility in a real-world environment. Data will be collected to understand impact to the user's daily life and physical activity through outcomes and participant feedback. The feedback obtained during this study will be essential to informing the design intended for commercialization.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-10.
Status change: Not Yet Recruiting → Recruiting 2025-10-09
Trial Details
NCT Number NCT07075198
Lead Sponsor Liberating Technologies, Inc.
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Hanger Clinic: Prosthetics & Orthotics, WillowWood, University of Hartford
Conditions Prosthesis User, Lower Limb Amputation Below Knee (Injury)
Enrollment 18 participants
Start Date 2025-10
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-10-14